Rapport Therapeutics, Inc. RAPP Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$111.48M-42.4% | -$78.31M-125% | ||
| $1.02M+21.2% | $839K— | ||
| $18.86M+84.2% | $10.24M— | ||
| -$87.47M-34.9% | -$64.83M— | ||
| $616K-74.4% | $2.41M— | ||
| -$187.47M— | —— | ||
| $270.79M+21.4% | $223.02M— | ||
| -$4.16M— | —— | ||
| -$88.09M-31.0% | -$67.23M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rapport Therapeutics, Inc. generate?
- Rapport Therapeutics, Inc. (RAPP) generated -$80.3M in operating cash flow over the trailing twelve months.
- What is Rapport Therapeutics, Inc.'s free cash flow?
- After $411.0K of capital expenditures, Rapport Therapeutics, Inc.'s free cash flow was -$80.7M over the trailing twelve months, down 16.8% year over year.
- Where does Rapport Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.